Sep 21, 2017· Comment from Association for Accessible Medicines (AAM)· FDA-2017-N-2697-0020
Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA-2017-N-2697: Submission of Proposed Recommendations for Industry on Developing Continuous Manufacturing of Solid Dosage Drug Products in Pharmaceutical Manufacturing. See attached file(s)